The overexpression of interleukin-37 (IL-37) as antiatherogenic inflammatory cytokine is protected against the inflammatory response by inhibiting proinflammatory cytokines [14, 15], and IL-37 inhibited atherosclerosis and was a novel cytokine for the prevention and treatment of atherosclerotic diseases [16]. Here, IL37 is linked to atherosclerosis.